Metabolites › RALVCBWUWHJOGL-OPMJLWCUSA-N

Myricatomentoside I

4-hydroxy-17-methoxy-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-10-one

RALVCBWUWHJOGL-OPMJLWCUSA-N CHEBI:172719 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
RALVCBWUWHJOGL-OPMJLWCUSA-N
InChI Key
RALVCBWUWHJOGL-OPMJLWCUSA-N
IUPAC name
4-hydroxy-17-methoxy-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-10-one
Preferred name
Myricatomentoside I
INN name
—
Synonym
—
ChEBI
CHEBI:172719

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles